Replies to post #4267 on GTC Biotherapeutics (fka GTCB)

[floblu14]

Earlier I had reported on this patent application dated April 26, 07 - which might help to explain GTC's technical advantage -

ANTIBODIES WITH ENHANCED ANTIBODY-DEPENDENT CELLULAR CYTOXICITY ACTIVITY, METHODS OF THEIR PRODUCTION AND USE

http://v3.espacenet.com/textdes?DB=EPODOC&IDX=WO2007048077&F=0&QPN=WO2007048077